Cover Image
Market Research Report

Analysis of the Cardiac Biomarker Diagnostics Market

Published by Frost & Sullivan Product code 341834
Published Content info 116 Pages
Delivery time: 1-2 business days
Price
Back to Top
Analysis of the Cardiac Biomarker Diagnostics Market
Published: September 30, 2015 Content info: 116 Pages
Description

Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment

The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates that are driving this market, the increasing use of point-of-care testing devices at ambulatory and at clinical settings spurs this market in the region. The push towards a more patient centric and wholesome care places imaging companies that can provide a more comprehensive diagnostic product are at an advantage in this market.

Table of Contents
Product Code: NF62-01-00-00-00

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Competitive Landscape
  • 4. Scope and Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Key Companies to Watch
  • 9. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

  • 1. Cardiac Diagnostics Industry Overview
  • 2. Cardiac Biomarkers Diagnostics Overview
  • 3. Market Background
  • 4. Market Background-Prevalence Rate
  • 5. Cardiac Diagnostics Overview
  • 6. Market Overview-Testing Procedure
  • 7. Factors Influencing Adoptability of Tests
  • 8. Defining Healthcare Trends in the Future

3. COMPETITIVE PLAYBOOK

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. Solutions Provided by Top Companies
  • 4. Important Partnerships-Cardiac Biomarker IVD Diagnostics
  • 5. Emerging Biomarkers for MI and Clinical Strength

4. EMERGING BIOMARKERS

  • 1. LDTs-Role in Cardiac Diagnostics
  • 2. Other Emerging Biomarkers

5. DRIVER AND RESTRAINTS-TOTAL CARDIAC BIOMARKER DIAGNOSTICS MARKET

  • 1. Market Drivers
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Market Restraints
  • 6. Restraints Explained
  • 7. Restraints Explained (continued)

6. FORECASTS AND TRENDS-TOTAL CARDIAC BIOMARKER DIAGNOSTICS MARKET

  • 1. Measurements
  • 2. Forecast Assumptions and Definitions
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Percent Revenue Breakdown by Segments
  • 6. Segment Lifecycle Analysis

7. COMPETITIVE ENVIRONMENT

  • 1. Market Share
  • 2. Market Share Analysis
  • 3. Overall Market Share Analysis
  • 4. Top Competitors
  • 5. Top Competitors (continued)
  • 6. Top Competitors (continued)
  • 7. Top Competitors (continued)
  • 8. Top Competitors (continued)

8. POCT SEGMENT ANALYSIS

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. POCT-Segment Share
  • 5. Segment Share Analysis
  • 6. Competitive Value Matrix
  • 7. Top POCT Devices in the US Market
  • 8. Competitive Product Analysis
  • 9. Competitive Product Analysis (continued)
  • 10. Competitive Product Analysis (continued)
  • 11. Competitive Product Analysis (continued)
  • 12. Competitive Product Analysis (continued)

9. LAB-BASED SEGMENT ANALYSIS

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Disease Type
  • 4. Growth Rate by Cardiac Disease
  • 5. Revenue Forecast Discussion
  • 6. Revenue Forecast Discussion (continued)
  • 7. Product Portfolio
  • 8. Product Portfolio (continued)
  • 9. Pricing Trends and Forecast
  • 10. Segment Share
  • 11. Segment Share Analysis
  • 12. Segment Share Analysis (continued)
  • 13. Competitive Value Matrix

10. THE FULL PICTURE-CARDIAC DIAGNOSTICS INDUSTRY OVERVIEW

  • 1. Cardiac Diagnostics Industry Overview
  • 2. Partnership Trends-Medical Device Diagnostics

11. CARDIAC IMAGING DIAGNOSTICS

  • 1. Industry Overview
  • 2. Industry Overview by Application
  • 3. New Market Opportunities
  • 4. Imaging Technology-Role in Patient Continuum

12. ECG IN CARDIAC DIAGNOSTICS

  • 1. Industry Overview
  • 2. Cardiac Monitoring by Application
  • 3. New Market Opportunities
  • 4. ECG Technology-Role in Patient Continuum

13. OPPORTUNITIES

  • 1. Opportunities-Companion Diagnostics
  • 2. Opportunities-Companion Diagnostics (continued)
  • 3. Opportunities-Companion Diagnostics (continued)
  • 4. Opportunities-Companion Diagnostics (continued)
  • 5. Digital Health and Diagnostics Inter Convergence Model-Cardiac Diagnostics
  • 6. Opportunity-Convergence of Imaging and IVD
  • 7. Opportunities-Key Companies to Watch

14. THE LAST WORD

  • 1. The Last Word-3 Big Predictions
  • 2. The Last Word-3 Big Predictions Discussion
  • 3. The Last Word-3 Big Predictions Discussion (continued)
  • 4. Legal Disclaimer

15. APPENDIX

  • 1. List of Others
  • 2. Methodology
  • 3. Learn More-Next Steps
  • 4. List of Exhibits
  • 5. List of Exhibits (continued)
  • 6. List of Exhibits (continued)
  • 7. List of Exhibits (continued)

List of Exhibits

  • Total Cardiac Biomarker Diagnostics Market: Competitive Landscape, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Industry Overview, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Overview, US, 2014
  • Cardiac Biomarker Diagnostics Prevalence Rate, US, 2009-2020
  • Total Cardiac Biomarker Diagnostics Market: Market Segmentation, US, 2014
  • Total Cardiac Biomarker Diagnostics Adoptability of Biomarker Tests, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Outlook, US, 2014 and 2024
  • Total Cardiac Biomarker Diagnostics Market: Game-changing Strategies, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Company Offerings, US, 2014
  • Total Cardiac Diagnostic Market: Notable Deals and Trends, US, 2011-2014
  • Net Improvement in Predicting of 30-day Mortality, Emerging Biomarkers, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: LDTs vs FDA-approved Tests, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Emerging Biomarkers, US,2014
  • Total Cardiac Biomarker Diagnostics Market: Key Market Drivers, US, 2015-2020
  • Total Cardiac Biomarker Diagnostics Market: Key Market Restraints, US, 2015-2020
  • Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Revenue Forecast, US, 2011-2021
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2021
  • Total Cardiac Biomarker Diagnostics Market: Segment Lifecycle Analysis, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown, US, 2014
  • Total Cardiac Biomarkers Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: SWOT Analysis, US, 2014
  • POCT Segment: Market Engineering Measurements, US, 2014
  • POCT Segment: Revenue Forecast, US, 2011-2021
  • POCT Segment: Percent Revenue Breakdown, US, 2014
  • POCT Segment: Company Segment Share Analysis by Top 4 Participants, US, 2014
  • POCT Segment: Competitive Analysis, US, 2014
  • POCT Segment: Product Analysis, US, 2014
  • POCT Segment: Top 10 products, US, 2014
  • Lab-based Tests Segment: Market Engineering Measurements, US, 2014
  • Lab-based Tests Segment: Revenue Forecast, US, 2011-2021
  • Lab-based Tests Segment: Revenue Forecast by Disease Type, US, 2011-2021
  • Lab-based Tests Segment: Growth Rate by Cardiac Disease, US, 2011-2021
  • Lab-based Tests Segment: Product Analysis, US, 2014
  • Lab-based Tests Segment: Average Price, US, 2009-2021
  • Lab-based Tests Segment: Percent Revenue Breakdown, US, 2014
  • Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • Lab-based Tests Segment: Competitive Analysis, US, 2014
  • Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
  • Total Cardiac Diagnostic Industry: Notable Deals and Trends, US, 2011-2014
  • Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
  • Total Cardiac Diagnostics Industry: Overview by Application, US, 2014
  • Total Cardiac Diagnostics Industry: Game-changing Strategies, US, 2014
  • Total Cardiac Diagnostics Industry: Patient Continuum, US, 2014
  • Total Cardiac Diagnostics Industry: ECG, US, 2014
  • Total Cardiac Monitoring Market: Market Segmentation, US, 2014
  • Total Cardiac Monitoring Market: Game-changing Strategies, US, 2014
  • Total Cardiac Diagnostics Industry: Patient Continuum, US, 2014
  • Total Cardiac Diagnostic Industry: Companies Pursuing CDx Opportunities, US, 2013-2015
  • Total Cardiac Diagnostic Industry: Pipeline Drugs for Each Cardiovascular Disease, US, 2013-2015
Back to Top